Featured series 
Tag: Emily Balskus
-
Nation & World
Vaginal bacteria must eat to survive — but how?
Chemical analysis brings understudied microbiome into sharper focus.
-
Nation & World
7 from Harvard among new Howard Hughes Medical Institute investigators
Seven Harvard affiliates are among 33 scientists from across the United States to be appointed as investigators by the Howard Hughes Medical Institute.
-
Nation & World
Emily Balskus wins $1M Waterman Award
Emily Balskus has won the Alan T. Waterman Award, the National Science Foundation’s most prestigious prize for scientists under 40 in the United States.
-
Nation & World
Microbes might manage your cholesterol
Researchers discover mysterious bacteria that break it down in the gut.
-
Nation & World
The ‘right’ diet
Professor Emily Balskus and her team have identified an entirely new class of enzymes that degrade chemicals essential for neurological health, but also help digest foods like nuts, berries, and tea, releasing nutrients that may impact human health.
-
Nation & World
Harvard microbe hunter wins Blavatnik Award
Emily Balskus will be honored on Sept. 23 with the Blavatnik National Award for Young Scientists for her work in tracking never-before-seen chemistry to specific bacteria in the human gut.
-
Nation & World
Gut microbes eat our medication
Study published in Science shows that gut microbes can chew up medications, with serious side effects.
-
Nation & World
Solving colibactin’s code
In an effort to understand how colibactin, a compound produced by certain strains of E. coli, may be connected to the development of colorectal cancer, Harvard researchers are exploring how the compound damages DNA to produce DNA adducts.
-
Nation & World
Microbial manufacturing
Emily Balskus and a team of researchers untangled how soil bacteria are able to manufacture streptozotocin, an antibiotic and anti-cancer compound.
-
Nation & World
Enzyme interference
Researchers discovered that Eggerthella lenta — a bacterium found in the guts of more than 30 percent of the population — can metabolize the cardiac drug digoxin in high enough quantities to render it ineffective. Now, a team of researchers has identified the culprit gene that produces the digoxin-metabolizing enzyme.
-
Nation & World
Microbial menace
A new study has shown that — under certain conditions — gut microbes can consume enough of a key nutrient to cause a deficiency in their hosts.
-
Nation & World
Gut details
New findings have the potential to help researchers more accurately identify microbiome enzymes and quantify their relative abundance.
